Program Schedule

PW6
Hepatitis C Treatment Options: Opportunities for the ID Practice $

Wednesday, October 8, 2014: 8:00 AM-12:00 PM
Room: The Pennsylvania Convention Center: 108-AB
IDSA Clinical Affairs Committee

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • outline non-invasive modalities for assessment of liver damage and genetic markers
  • describe latest treatments approved for mono HCV and HCV/HIV co-infection
  • outline the basics of care of the compensated cirrhotic patients

Target Audience: Microbiologists, Members-in-training, Infectious diseases physicians, Infectious diseases pediatricians, Hospital epidemiologists, HIV specialists, HIV clinicians, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Adult ID

Pre-Meeting Workshop Moderators:  Eliot Godofsky, MD, Bach and Godofsky and David Thomas, MD, MPH, FIDSA, Johns Hopkins University School of Medicine

CME Credits: Maximum of 4.00 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 4.0 knowledge-based contact hours (0.4 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-086-L02-P

Disclosures:

E. Godofsky, AbbVie: Research Contractor and Scientific Advisor, Consulting fee and Research support
Janssen: Research Contractor and Scientific Advisor, Consulting fee and Research support
Gilead Sciences: Research Contractor and Scientific Advisor, Consulting fee and Research support
Achillion: Research Contractor, Research support
Boeringer Ingelheim: Research Contractor, Research support
Anadys: Research Contractor, Research support
Genentech: Research Contractor and Scientific Advisor, Consulting fee and Research support
Merck: Research Contractor, Research support
Novartis: Research Contractor, Research support
Vertex: Research Contractor, Research support

D. Thomas, None

D. Thomas, None

T. G. Slama, None

S. Naggie, Abbvie: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
Achillion: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
BMS: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
Gillead: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
Vertex: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
IAS-USA: Collaborator and Member, Educational Activities or Lectures for this Company Generates Revenue for Duke
IDSA: Collaborator and Member, Educational Activities or Lectures for this Company Generates Revenue for Duke

M. Sulkowski, AbbVie: Investigator and Scientific Advisor, Consulting fee and Research grant
BMS: Investigator and Scientific Advisor, Consulting fee and Research support
Gilead: Investigator and Scientific Advisor, Consulting fee and Research support
Janssen: Investigator and Scientific Advisor, Consulting fee and Research support
Merck: Investigator and Scientific Advisor, Consulting fee and Research support

R. Baden, Gilead Sciences: Investigator and Scientific Advisor, Consulting fee and Research support
Vertex Pharamceuticals: Grant Investigator, Educational grant

E. Godofsky, AbbVie: Research Contractor and Scientific Advisor, Consulting fee and Research support
Janssen: Research Contractor and Scientific Advisor, Consulting fee and Research support
Gilead Sciences: Research Contractor and Scientific Advisor, Consulting fee and Research support
Achillion: Research Contractor, Research support
Anadys: Research Contractor, Research support
Boeringer Ingelheim: Research Contractor, Research support
Genentech: Research Contractor and Scientific Advisor, Consulting fee and Research support
Merck: Research Contractor, Research support
Novartis: Research Contractor, Research support
Vertex: Research Contractor, Research support

R. Nahass, Abbvie, Merck, Gilead, Janssen, BMS: Investigator, Research support
Gilead, Merck, Janssen: Speaker's Bureau, Speaker honorarium
Janssen, BMS, Gilead: Scientific Advisor, Consulting fee

See more of: Premeeting Session

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek